Skip to content
10-Q

Quarterly Report

Advanced Biomed Inc ADVB

0001213900-26-016458

← back to feed
Filed
Feb 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Dec 31, 2025 21.64M sh
Shares Diluted Q2 2026 · Dec 31, 2025 21.64M sh
Shares Diluted Q2 2026 · Dec 31, 2024 20M sh
Shares Diluted Q2 2026 · Dec 31, 2024 20M sh
Shares Outstanding Q2 2026 · Dec 31, 2025 21.64M sh
Capex Q2 2026 · Dec 31, 2025 $14.68K
Capex Q2 2026 · Dec 31, 2024 $9.29K
Operating Cash Flow Q2 2026 · Dec 31, 2025 −$1.12M
Operating Cash Flow Q2 2026 · Dec 31, 2024 −$871.52K
Cash And Equivalents Q2 2026 · Dec 31, 2025 $2.6M
Cash And Equivalents restated Q2 2026 · Dec 31, 2024 $2.65M
Stockholders Equity Q2 2026 · Dec 31, 2025 $9.48M
Stockholders Equity Q2 2026 · Jun 30, 2025 $3.48M
Stockholders Equity Q2 2026 · Dec 31, 2024 $619.03K
Stockholders Equity Q2 2026 · Jun 30, 2024 $1.66M
Current Liabilities Q2 2026 · Dec 31, 2025 $1.25M
Current Liabilities Q2 2026 · Jun 30, 2025 $10.09M
Total Liabilities Q2 2026 · Dec 31, 2025 $1.37M
Total Liabilities Q2 2026 · Jun 30, 2025 $10.24M
Current Assets Q2 2026 · Dec 31, 2025 $10.73M
Current Assets Q2 2026 · Jun 30, 2025 $13.24M
Total Assets Q2 2026 · Dec 31, 2025 $10.85M
Total Assets Q2 2026 · Jun 30, 2025 $13.72M
Eps Diluted Q2 2026 · Dec 31, 2025 $0.31
Eps Diluted Q2 2026 · Dec 31, 2025 $0.30
Eps Diluted restated Q2 2026 · Dec 31, 2024 −$0.05
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.06
Eps Basic Q2 2026 · Dec 31, 2025 $0.31
Eps Basic Q2 2026 · Dec 31, 2025 $0.30
Eps Basic restated Q2 2026 · Dec 31, 2024 −$0.05
Eps Basic Q2 2026 · Dec 31, 2024 −$0.06
Sga Expense Q2 2026 · Dec 31, 2025 $210.31K
Sga Expense Q2 2026 · Dec 31, 2025 $369.6K
Sga Expense restated Q2 2026 · Dec 31, 2024 $67.67K
Sga Expense restated Q2 2026 · Dec 31, 2024 $127.55K
Rd Expense Q2 2026 · Dec 31, 2025 $186.33K
Rd Expense Q2 2026 · Dec 31, 2025 $421.91K
Rd Expense restated Q2 2026 · Dec 31, 2024 $212.4K
Rd Expense restated Q2 2026 · Dec 31, 2024 $380.09K
Net Income Q2 2026 · Dec 31, 2025 $6.86M
Net Income Q2 2026 · Dec 31, 2025 $6.47M
Net Income Q2 2026 · Dec 31, 2024 −$907.9K
Net Income Q2 2026 · Dec 31, 2024 −$1.17M